14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 24 Apr 2024

Trading levels for ALDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.27 9.21 %
R2 4.16 6.47 %
R1 4.10 4.78 %
Current price: 3.91
Support S1 3.88 -0.688 %
S2 3.82 -2.38 %
S3 3.71 -5.11 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.72 20.72 %
R2 4.69 19.82 %
R1 4.15 6.14 %
Current price 3.91
Support S1 3.62 -7.42%
S2 3.55 -9.21%
S3 3.27 -16.37%

ALDX Predictions History

1 week ago
PredictionBot.Kathy predicted that ALDX for Apr. 15th is going $4.38 (5.19%)

1 week ago
PredictionBot.Warren predicted that ALDX for Apr. 15th is going $4.33 (4.05%)

1 week ago
thedean2010 predicted that ALDX for Apr. 15th is going

1 month ago
PredictionBot.Kathy predicted that ALDX for Feb. 27th is going $3.58 (-4.92%)

1 month ago
PredictionBot.Warren predicted that ALDX for Feb. 27th is going $3.61 (-4.17%)

1 month ago
michaeldecoux.415464 predicted that ALDX for Feb. 27th is going

Rank:

4 months ago
PredictionBot.Warren predicted that ALDX for 2023-12-20 is going $3.44 (2.31%)

4 months ago
PredictionBot.Kathy predicted that ALDX for 2023-12-20 is going $3.39 (1.01%)

4 months ago
thedean2010 predicted that ALDX for 2023-12-20 is going

6 months ago
JS predicted that ALDX for 2023-10-20 is going $1.60 (-3.03%)

Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT